MS vs UBS: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
MS is the larger of the two ($330.78B market cap): the incumbent the market prices for continued execution (15.45x forward earnings, beta 1.22). UBS is the smaller challenger ($172.87B), cheaper on forward earnings (12.80x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
MS vs UBS: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | MS | UBS | What it tells you |
|---|---|---|---|
| Market cap | $330.78B | $172.87B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 15.45 | 12.80 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 17.01 | 33.38 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.22 | 0.83 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 76% of range | 87% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 3.18 | 1.77 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: UBS is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how MS and UBS affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MS and UBS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MS and UBS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Morgan Stanley (MS) do?
Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. It operates through three segments: Institutional Securities (investment banking, equity and fixed-income trading, prime brokerage, and research), Wealth Management (financial-advisor-led brokerage, investment advisory, lending, and banking services for individuals and families), and Investment Management (equity, fixed income, alternatives, and liquidity strategies for institutions and intermediaries). The firm earns revenue through advisory and underwriting fees, trading gains, and, increasingly, recurring asset-based fees tied to the value of client assets across its wealth and investment management platforms. The current Morgan Stanley took its modern shape through the 1997 merger with Dean Witter Discover and a string of subsequent acquisitions, most notably E*TRADE (2020) and Eaton Vance (2021), which dramatically expanded its self-directed brokerage and asset management capabilities. Ted Pick became Chairman and CEO at the start of 2024, succeeding James Gorman, who had led the firm since 2010 and orchestrated its transformation toward fee-based businesses. Under Pick, the integrated-firm strategy emphasizes cross-selling across all three segments and driving client assets toward fee-based relationships to generate more predictable earnings.
What does UBS Group (UBS) do?
UBS Group is a Swiss-headquartered global financial-services firm built around wealth management. Its Global Wealth Management arm advising high-net-worth and ultra-high-net-worth clients is the largest such franchise in the world, and it is complemented by an asset-management business, a leading Swiss universal bank serving domestic retail and corporate clients, and an investment bank focused on advisory, markets, and financing. Because much of its revenue is fee-based, tied to client assets and advice rather than pure lending, UBS is often viewed as a higher-quality, less credit-cyclical bank than many peers, though its investment bank and lending books still carry market and credit exposure.
MS vs UBS: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- MS drivers: Wealth management as a recurring-revenue engine; Capital-markets cycle recovery.
- UBS drivers: World-leading wealth management; Credit Suisse integration and synergies.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. For UBS, the dominant near-term risk is integration execution: absorbing Credit Suisse is a large, multi-year effort, and client attrition, technology migration, legal legacy issues, or cost overruns could reduce the expected synergies.
MS or UBS: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MS if you believe its drivers more; UBS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MS and UBS guides.
MS vs UBS: the full fundamentals
MS. Morgan Stanley's trailing P/E of roughly 19 to 20 times sits modestly above its own 5-year historical average of around 14 to 15 times, reflecting the market's recognition of the firm's successful shift toward more durable, fee-based earnings. The ROTCE of 21.6% for full-year 2025 demonstrates that the integrated-firm model is generating returns well above most peers' cost of equity, though sustaining that level depends on continued strength in both capital markets and wealth inflows. At a forward P/E of approximately 17.6 times, the stock is not priced as a deep-value name, meaning expectations for continued earnings growth are already embedded in the current price.
UBS. These figures are approximate and tied to the asOf date; verify live numbers before acting. UBS is valued as a wealth-led global bank, so the market weighs the durability of fee income and integration synergies against Swiss capital-rule uncertainty and investment-bank volatility. Bank earnings can be lumpy, and capital rules can change how much profit reaches shareholders, so judge it on franchise quality and execution rather than a single multiple.
Headline figures (approximate, 2026-06-27): MS shows revenue (full year 2025) ~$70.6 billion, net income (full year 2025) ~$13.4 billion (approx., based on ~$10.21 EPS on ~1.58B diluted shares), eps (ttm) ~$11.04, p/e ratio (ttm) ~19-20x; UBS shows profitability Q1 2026 net profit around $3 billion, up sharply year over year, with roughly 17-18% return on CET1 capital, wealth inflows Global Wealth Management attracted tens of billions in net new assets in Q1 2026, led by Asia-Pacific strength, integration On track to complete most Credit Suisse integration by end-2026, targeting billions in total cost synergies, efficiency Cost-income ratio near 70% in Q1 2026, with a long-term target closer to the high-60s percent.
The bottom line: MS vs UBS
MS and UBS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MS and UBS exposure against your real portfolio. It is not an investment adviser.
Wondering how MS or UBS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Morgan Stanley with AI
Connect the broker you already use and ask Walnut's AI how MS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between MS and UBS?
+
Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. UBS Group is a Swiss-headquartered global financial-services firm built around wealth management. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is MS or UBS the better stock?
+
Neither is universally better. MS is the larger incumbent; UBS is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, MS or UBS?
+
On forward P/E (as of August 2026), MS trades at 15.45x and UBS at 12.80x, so UBS is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both MS and UBS?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of MS vs UBS?
+
MS: A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally. UBS: The dominant near-term risk is integration execution: absorbing Credit Suisse is a large, multi-year effort, and client attrition, technology migration, legal legacy issues, or cost overruns could reduce the expected synergies. Regulatory and capital risk is significant, as Swiss authorities have pushed to raise capital requirements for UBS given its size relative to Switzerland, which could constrain dividends and buybacks. As a global bank, UBS is exposed to market downturns that reduce client assets and fee income, to investment-bank volatility, and to credit and counterparty risk. It is also a Swiss company whose US-listed shares carry currency exposure between the Swiss franc, the euro, the dollar, and other currencies. Legal and litigation legacies inherited from Credit Suisse add further uncertainty.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell MS or UBS; figures are approximate and dated (as of August 2026). Verify current data before investing.